
|Articles|November 1, 2002
Supplements and Featured Publications
- Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
- Volume 8
- Issue 17 Suppl
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
3
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
4
Value-Based Care Needs a Rebrand. Will 2026 Be the Year It Finally Gets One?
5




























































